TrialArthritis research & therapy2023

Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept.

Louis Bessette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.